SEC Form 4 · accession 0001593968-16-000538
UNIVERSAL AMERICAN CORP. · UAM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Erin Page
Officer — President, Medicare
Period of report
Feb 4, 2016
Accepted (ET)
Feb 8, 2016 · 7:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001514128
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 4, 2016 | A | 23,448 | $0.00 | A | 261,585 | D | |
| Common StockF3,F4 | Feb 4, 2016 | A | 23,448 | $0.00 | A | 285,033 | D | |
| Common StockF5,F6 | Feb 6, 2016 | F | 1,909 | $5.70 | D | 283,124 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F7 | $6.09 | Feb 4, 2016 | A | 21,957 | A | — | Feb 4, 2021 | Common Stock | 21,957 | 21,957 | D |
| Stock Option (Right to Buy)F8 | $6.09 | Feb 4, 2016 | A | 21,957 | A | — | Feb 4, 2021 | Common Stock | 21,957 | 21,957 | D |
Explanation of responses
- F1Represents grant of restricted stock which vests in four equal annual installments beginning February 4, 2017.
- F2Represents common stock including 224,570 shares of unvested restricted stock.
- F3Represents grant of performance shares which vest 25% per year over four years subject to the Company having met a specified target of stock price appreciation.
- F4Represents common stock including 248,018 shares of unvested restricted stock.
- F5Shares withheld by issuer to satisfy statutory tax withholding on vesting of restricted stock.
- F6Represents common stock including 242,172 shares of unvested restricted stock.
- F7Represents grant of stock options which vests in four equal annual installments beginning February 4, 2017.
- F8Represents grant of performance options which vest 25% per year over four years subject to the Company having met a specified target of stock price appreciation.